Oxazine conjugated nanoparticle detects in vivo hypochlorous acid and peroxynitrite generation.

The current lack of suitable probes has limited the in vivo imaging of reactive oxygen/nitrogen species (ROS/RNS). ROS/RNS are often generated by ischemia-induced inflammation; defining the extent of tissue involvement or ROS/RNS-related damage would have a significant clinical impact. We present the preparation and demonstration of a fluorogenic sensor for monitoring peroxynitrite (ONOO(-)) and myeloperoxidase (MPO) mediated hypochlorous acid (HOCl/OCl(-)) production. The sensor consists of a long circulating biocompatible nanoparticle that targets phagocytic cells in vivo and is coated with approximately 400 quenched oxazine fluorophores that are released by reaction with HOCl or ONOO(-) but are stable toward oxidants such as hydroxyl radical, hydrogen peroxide, and superoxide. MPO-dependent probe activation is chloride ion dependent and is negated in flow cytometry studies of MPO inhibitor treated neutrophils. Fluorescence reflectance imaging and microscopic fluorescence imaging in mouse hearts after myocardial infarction showed probe release into neutrophil-rich ischemic areas, making this ROS/RNS sensor a novel prognostic indicator.

[1]  David Piwnica-Worms,et al.  Bioluminescence imaging of myeloperoxidase activity in vivo , 2009, Nature Medicine.

[2]  N. Murthy,et al.  Hydrocyanines: a class of fluorescent sensors that can image reactive oxygen species in cell culture, tissue, and in vivo. , 2009, Angewandte Chemie.

[3]  Ralph Weissleder,et al.  Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase , 2008, Proceedings of the National Academy of Sciences.

[4]  D. Lefkowitz,et al.  Microglia and myeloperoxidase: a deadly partnership in neurodegenerative disease. , 2008, Free radical biology & medicine.

[5]  B. Dickinson,et al.  A targetable fluorescent probe for imaging hydrogen peroxide in the mitochondria of living cells. , 2008, Journal of the American Chemical Society.

[6]  Christopher P. Johnson,et al.  Reactive oxygen and reactive nitrogen as signaling molecules for caspase 3 activation in acute cardiac transplant rejection. , 2008, Antioxidants & redox signaling.

[7]  P. Libby,et al.  Activatable Magnetic Resonance Imaging Agent Reports Myeloperoxidase Activity in Healing Infarcts and Noninvasively Detects the Antiinflammatory Effects of Atorvastatin on Ischemia-Reperfusion Injury , 2008, Circulation.

[8]  Ralph Weissleder,et al.  Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis , 2008, Circulation.

[9]  R. Weissleder,et al.  Utility of a new bolus-injectable nanoparticle for clinical cancer staging. , 2007, Neoplasia.

[10]  Evan W. Miller,et al.  Fluorescent probes for nitric oxide and hydrogen peroxide in cell signaling. , 2007, Current opinion in chemical biology.

[11]  P. Libby,et al.  A novel fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages , 2009 .

[12]  P. Libby,et al.  The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions , 2007, The Journal of experimental medicine.

[13]  D. Madtes,et al.  Myeloperoxidase Inactivates TIMP-1 by Oxidizing Its N-terminal Cysteine Residue , 2007, Journal of Biological Chemistry.

[14]  V. Cameron,et al.  Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. , 2007, Journal of the American College of Cardiology.

[15]  G. Rogler,et al.  In vivo treatment with the herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium‐induced colitis , 2007, Clinical and experimental immunology.

[16]  Ralph Weissleder,et al.  Dual Channel Optical Tomographic Imaging of Leukocyte Recruitment and Protease Activity in the Healing Myocardial Infarct , 2007, Circulation research.

[17]  Evan W. Miller,et al.  Molecular imaging of hydrogen peroxide produced for cell signaling , 2007 .

[18]  Vasilis Ntziachristos,et al.  Fluorescence Tomography and Magnetic Resonance Imaging of Myocardial Macrophage Infiltration in Infarcted Myocardium In Vivo , 2007, Circulation.

[19]  S. Lippard,et al.  Metal-based turn-on fluorescent probes for sensing nitric oxide. , 2007, Accounts of chemical research.

[20]  N. Sharpless,et al.  ROS as a tumour suppressor? , 2006, Nature Cell Biology.

[21]  P. Libby,et al.  Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease , 2006, Proceedings of the National Academy of Sciences.

[22]  S. Lippard,et al.  Visualization of nitric oxide in living cells by a copper-based fluorescent probe , 2006, Nature chemical biology.

[23]  Dan Yang,et al.  A highly selective fluorescent probe for the detection and imaging of peroxynitrite in living cells. , 2006, Journal of the American Chemical Society.

[24]  R. Weissleder,et al.  Factor XIII Deficiency Causes Cardiac Rupture, Impairs Wound Healing, and Aggravates Cardiac Remodeling in Mice With Myocardial Infarction , 2006, Circulation.

[25]  Shingo Matsumoto,et al.  Simultaneous molecular imaging of redox reactions monitored by Overhauser-enhanced MRI with 14N- and 15N-labeled nitroxyl radicals , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Evan W. Miller,et al.  Boronate-based fluorescent probes for imaging cellular hydrogen peroxide. , 2005, Journal of the American Chemical Society.

[27]  R. Weissleder,et al.  A pilot study of lymphotrophic nanoparticle-enhanced magnetic resonance imaging technique in early stage testicular cancer: a new method for noninvasive lymph node evaluation. , 2005, Urology.

[28]  S. Lippard,et al.  Conjugated polymer-based fluorescence turn-on sensor for nitric oxide. , 2005, Organic letters.

[29]  Ralph Weissleder,et al.  Sensitive, Noninvasive Detection of Lymph Node Metastases , 2004, PLoS medicine.

[30]  R. Weissleder,et al.  Human myeloperoxidase: A potential target for molecular MR imaging in atherosclerosis , 2004, Magnetic resonance in medicine.

[31]  B. Hyman,et al.  Neuronal expression of myeloperoxidase is increased in Alzheimer's disease , 2004, Journal of neurochemistry.

[32]  S. Lippard,et al.  Dirhodium tetracarboxylate scaffolds as reversible fluorescence-based nitric oxide sensors. , 2004, Journal of the American Chemical Society.

[33]  R. Weissleder,et al.  Uptake and metabolism of a dual fluorochrome Tat-nanoparticle in HeLa cells. , 2003, Bioconjugate chemistry.

[34]  Hideo Utsumi,et al.  In vivo electron spin resonance-computed tomography/nitroxyl probe technique for non-invasive analysis of oxidative injuries. , 2003, Archives of biochemistry and biophysics.

[35]  Ralph Weissleder,et al.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.

[36]  J. Heinecke.  Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. , 2003, The American journal of cardiology.

[37]  Y. Urano,et al.  Development of Novel Fluorescence Probes That Can Reliably Detect Reactive Oxygen Species and Distinguish Specific Species* 210 , 2003, The Journal of Biological Chemistry.

[38]  R. Mason,et al.  Noninvasive diagnostic tool for inflammation-induced oxidative stress using electron spin resonance spectroscopy and an extracellular cyclic hydroxylamine. , 2002, Archives of biochemistry and biophysics.

[39]  A. Levitzki,et al.  ROS, stress‐activated kinases and stress signaling in cancer , 2002, EMBO reports.

[40]  T. Nagano,et al.  Bioimaging of nitric oxide. , 2002, Chemical reviews.

[41]  R. Weissleder,et al.  MR lymphangiography for detection of minimal nodal disease in patients with prostate cancer. , 2002, Academic radiology.

[42]  R. Weissleder,et al.  Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets. , 2002 .

[43]  E J Topol,et al.  Association between myeloperoxidase levels and risk of coronary artery disease. , 2001, JAMA.

[44]  A. Jackson,et al.  The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. , 2001, Mutation research.

[45]  A. Carr,et al.  Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[46]  R. Fenna,et al.  X-ray Crystal Structure and Characterization of Halide-binding Sites of Human Myeloperoxidase at 1.8 Å Resolution* , 2000, The Journal of Biological Chemistry.

[47]  J. Heinecke,et al.  Nitrogen dioxide radical generated by the myeloperoxidase‐hydrogen peroxide‐nitrite system promotes lipid peroxidation of low density lipoprotein , 1999, FEBS letters.

[48]  S. Hazen,et al.  Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. , 1999, The Journal of clinical investigation.

[49]  N. Maeda,et al.  Severe Impairment in Early Host Defense againstCandida albicans in Mice Deficient in Myeloperoxidase , 1999, Infection and Immunity.

[50]  J. Dillon,et al.  Oxidation of biological electron donors and antioxidants by a reactive lactoperoxidase metabolite from nitrite (NO2-): an EPR and spin trapping study. , 1999, Free radical biology & medicine.

[51]  R Weissleder,et al.  High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.

[52]  R. Schulz,et al.  Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. , 1997, Cardiovascular research.

[53]  J. Zweier,et al.  Measurement of Nitric Oxide and Peroxynitrite Generation in the Postischemic Heart , 1996, The Journal of Biological Chemistry.

[54]  P. Nibbering,et al.  Mean cell volume of human blood leucocytes and resident and activated murine macrophages. , 1990, Journal of immunological methods.